Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Jul 24, 2014; 3(2): 139-143
Published online Jul 24, 2014. doi: 10.5410/wjcu.v3.i2.139
Published online Jul 24, 2014. doi: 10.5410/wjcu.v3.i2.139
Figure 1 Cause-specific survival curves of castration-resistant prostate cance patients according to serum carboxy-terminal pyridinoline cross-linked telopeptide parts of type-1 collagen levels (A) and alkaline phosphatase levels (B).
- Citation: Endo T, Kamiya N, Suzuki H, Oka R, Lee FC, Utsumi T, Yano M, Kamijima S, Kawamura K, Imamoto T, Ichikawa T. Bone markers predict survival in castration-resistant prostate cancer patients treated with docetaxel. World J Clin Urol 2014; 3(2): 139-143
- URL: https://www.wjgnet.com/2219-2816/full/v3/i2/139.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i2.139